Twitter | Pretraživanje | |
Frank Vinluan
When it comes to , size matters. Here's why thinks the smaller size of Cas14 gives it advantages for developing new drugs and diagnostics
Mammoth Biosciences set out to develop CRISPR-based diagnostics that could be faster and cheaper than what’s available today. Those diagnostics are still
Xconomy Xconomy @Xconomy
Reply Retweet Označi sa "sviđa mi se" More